By Cindy Lombard, WHNP-BC
Founder, Essential Woman LLC

If I asked you what the number one killer of women is, what would you say?
Breast cancer?
Ovarian cancer?
The answer surprises many women.
Heart disease remains the leading cause of death among women.
Yet despite this reality, many women are told, “Your cholesterol looks fine,” after receiving only a standard lipid panel.
Sometimes that’s enough.
Sometimes it isn’t.
One of the biggest lessons I’ve learned over the past few years is that normal cholesterol numbers don’t always tell the whole story.
Today, we have the ability to look much deeper into cardiovascular risk. We can identify women who appear healthy on the surface but may have underlying risk factors that deserve attention long before symptoms develop.
The goal isn’t to order advanced testing for everyone.
The goal is to identify the women who stand to benefit most.
A traditional lipid panel measures:
These are valuable tests and remain an important part of cardiovascular prevention.
But they’re only part of the story.
Think of a standard lipid panel as looking at the cover of a book.
Advanced cardiovascular testing helps you read the chapters inside.
If your father, brother, or son had a heart attack before age 55—or your mother, sister, or daughter before age 65—you may carry inherited risk that isn’t obvious on a standard cholesterol panel.
This is one situation where tests such as Lipoprotein(a) and, in selected cases, Apolipoprotein B (ApoB) may provide valuable additional information. Current guidelines recommend measuring Lp(a) at least once in a lifetime because elevated levels are largely genetic and can significantly increase cardiovascular risk.
Pregnancy is often called a woman’s first cardiovascular stress test.
A history of:
doesn’t just matter during pregnancy.
It provides important clues about your long-term cardiovascular health.
These women deserve lifelong attention to cardiovascular risk factors, not just postpartum follow-up. Recent guidelines recognize pregnancy-related complications as important cardiovascular risk enhancers.
Whether menopause occurred naturally or after surgery, estrogen loss before the expected age is associated with increased cardiovascular risk over time.
If you entered menopause before age 45, your conversation about heart health should be more comprehensive than a routine cholesterol check.
Insulin resistance affects much more than blood sugar.
It contributes to inflammation, abnormal lipoproteins, fatty liver disease, and accelerated plaque formation.
Even when LDL cholesterol appears “normal,” cardiovascular risk may be higher than expected.
In many of these women, additional testing—such as ApoB—may help identify residual risk that a standard lipid panel doesn’t fully capture.
Conditions such as:
create chronic inflammation throughout the body.
Inflammation plays an important role in atherosclerosis, making cardiovascular prevention especially important in these women.
Not all body fat carries the same risk.
Visceral fat—the fat surrounding our internal organs—is metabolically active.
It produces inflammatory chemicals, worsens insulin resistance, and contributes to cardiovascular disease.
This is one reason I spend less time talking about weight and much more time talking about metabolic health.
Sometimes your body sends subtle signals before disease develops.
Markers such as:
may provide additional insight in selected patients, particularly when considered alongside the rest of the clinical picture.
No single marker should ever be interpreted in isolation.
Instead, we look for patterns.
Even years after quitting, smoking leaves a lasting imprint on cardiovascular health.
Former smokers often benefit from a more individualized cardiovascular risk discussion.
One of the most common stories I hear is:
“Everyone in my family has heart disease…but my cholesterol has always been normal.”
That’s exactly the type of woman who deserves a deeper conversation.
Not every woman needs every test.
The right testing depends on your personal history, family history, and overall risk profile.
Depending on your situation, additional evaluation may include:
The newest cardiovascular guidelines also place greater emphasis on Lp(a), selective ApoB testing, and coronary artery calcium scoring to refine cardiovascular risk assessment beyond the traditional lipid panel.
Advanced testing isn’t about finding something wrong.
It’s about finding opportunities.
An opportunity to improve nutrition.
To increase muscle.
To reduce inflammation.
To improve sleep.
To treat high blood pressure earlier.
To manage cholesterol more effectively.
To prevent disease instead of reacting to it.
That is what preventive medicine should be.
Not every woman needs advanced cardiovascular testing.
But many women deserve a conversation about whether it could benefit them.
If you have a strong family history of heart disease, experienced pregnancy complications, entered menopause early, live with diabetes or autoimmune disease, have persistent inflammation, or simply feel that your personal story doesn’t match your “normal” cholesterol numbers, it may be time to ask a different question.
Not…
“Is my cholesterol normal?”
But…
“Am I truly understanding my cardiovascular risk?”
Because our goal isn’t simply to live longer.
It’s to protect the health, vitality, and independence that make those extra years worth living.
The best cardiovascular care isn’t about ordering more tests for everyone. It’s about asking better questions, identifying the women who may benefit from a deeper evaluation, and creating a personalized plan based on their biology, their history, and their goals.
Because every woman deserves more than a number on a lab report. She deserves a roadmap to a healthier future.
Join our list
Navigate
Contact
Home
About
Service
Blog
FAQ
Contact
Email: Myessentialwoman@gmail.com
Fax: 352-995-0004
1405 SW 6th Ave, Ocala, FL 34471
Licenses
ANCC # 104415489
APRN9191380
Phone: 352-425-1704
Receive updates on special promotions, exclusive events and announcements.
Thank You!